Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2014

Aug 19, 2014

30198_dirs_2014-08-19_46b98541-df0f-44a3-a541-36e5062711d5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2014-08-15

Reporting Person: GREGG TERRANCE H (Director, CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-08-15 Common Stock M 5000.0 $6.85 Acquired 400626 Direct
2014-08-15 Common Stock S 5000.0 $44.0581 Disposed 395626 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-08-15 Non-Qualified Stock Option (right to buy) $6.85 M 5000.0 Disposed 2017-06-19 Common Stock (5000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 11461 Indirect
Common Stock 662889 Indirect

Footnotes

F1: Included in this number are 157,423 unvested restricted stock units granted on March 8, 2014, 5,078 of which shall vest each month through March 8, 2017, and 96,485 unvested restricted stock units granted on March 11, 2013, 5,078 of which shall vest each month through March 11, 2016.

F2: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.